Summary
The effectiveness of Lipiodol (iodized oil) in transcatheter arterial embolization (TAE) of hepatocellular carcinoma (HCC) was retrospectively evaluated using statistical analysis. A total of 343 HCC patients who underwent TAE at 5 institutions between 1984 and 1989 were divided into 2 groups: the GS-TAE group underwent TAE with Gelfoam sponge alone, whereas the LP-TAE group was given Lipiodol (LP) immediately before GS-TAE. The statisticalT value calculated for the LP-TAE group showed that the administration of LP, the tumor size, intrahepatic metastasis, portal vein infiltration, and serum total bilirubin and alpha-fetoprotein levels significantly (P<0.01) affected the patients' survival. Both the cumulative survival determined using the Kaplan-Meier model and the cumulative hazard calculated using Cox's proportional hazard model differed significantly (P<0.01) between the GS-TAE group and the LP-TAE group (log-rank test). These results confirmed the effectiveness of LP used in combination with Gelfoam sponge for TAE of HCC.
Similar content being viewed by others
References
Beers BV, Roche A, Cauquil P, Jamart J, Pariente D, Ajavon Y (1989) Transcatheter arterial chemotherapy using doxorubicin, iodized oil and Gelfoam embolization in hepatocellular carcinoma. Acta Radiol 30:415
Chuang VP, Wallace S (1981) Hepatic artery embolization in the treatment of hepatic neoplasms. Radiology 140:51
Clouse ME, Lee RGL, Duszlak EJ, Lokich JJ, Trey C, Alday MR, Yoburn DC, Diamond J, Crosson AW, Costello P (1983) Peripheral hepatic artery embolization for primary and secondary hepatic neoplasms. Radiology 147:407
Cox DR (1972) Regression models and life tables (with discussion). J R Stat Soc Ser B 34:187
Cox DR, Oakes D (1984) Analysis of survival data. Chapman and Hall, London
Falkson G, MacIntyre JM, Moertel CG, Johnson LA, Scherman RC (1984) Primary liver cancer: an Eastern Cooperative Group trial. Cancer 54:970
Kalbfreisch JD, Prentice RL (1973) Marginal likelihoods based on Cox's regression and life model. Biometrica 60:267
Kalbfreisch JD, Prentice RL (1980) The statistical analysis of failure time data. John Wiley & Sons, New York
Nakamura H, Tanaka T, Hori S, Yoshioka H, Kuroda C, Okamura J, Sakurai M (1983) Transcatheter embolization of hepatocellular carcinoma: assessment of efficacy in cases of resection following embolization. Radiology 147:401
Nakamura H, Hashimoto T, Oi H, Sawada S (1989) Transcatheter oily chemoembolization of hepatocellular carcinoma. Radiology 170:783
Nishioka M, Fukuda T, Fukumoto Y, Kan D, Nawada J, Takemoto T, Miyaji T (1979) Clinicopathological studies on patients with hepatocellular carcinoma. II. Prognosis forecasting in patients by a discriminant analysis. Jpn J Clin Pathol 27:519
Ohishi H, Uchida H, Yoshimura H, Ohue S, Ueda J, Katsuragi M, Matsuo N, Hosogi Y (1985) Hepatocellular carcinoma detected by iodized oil. Radiology 154:25
Sciarrino E, Simonetti RG, Moli SG, Pagliaro L (1985) Adriamycin treatment for hepatocellular carcinoma: experience with 109 patients. Cancer 56:2751
Takayasu K, Shima Y, Muramatsu Y, Moriyama N, Yamada T, Makuuchi M, Hasegawa H, Hirohashi S (1987) Hepatocellular carcinoma: treatment with intraarterial iodized oil with and without chemotherapeutic agents. Radiology 162:345
Wheeler PG, Melia W, Dubbins P, Jones B, Nunnerley H, Johnson P, Williams R (1979) Non-operative arterial embolization in primary liver tumors. BMJ 2:242
Yasumori K (1986) Transcatheter therapy for unresectable hepatocellular carcinoma — analysis of prognostic factors, and predicted prognosis by multivariate analysis. Nippon Act Radiol 46:791
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Nakao, N., Uchida, H., Kamino, K. et al. Effectiveness of Lipiodol in transcatheter arterial embolization of hepatocellular carcinoma. Cancer Chemother. Pharmacol. 31 (Suppl 1), S72–S76 (1992). https://doi.org/10.1007/BF00687110
Issue Date:
DOI: https://doi.org/10.1007/BF00687110